UNION is a clinical-stage, diversified pharmaceutical company focusing on immunology and infectious diseases. Our current portfolio is comprised of two medicinal compound classes with established modes of action that have significant potential to address underserved medical needs
UNION comprises a global team with drug development experience from more than 15 successfully marketed medicines
Read about our latest research, clinical development and company highlight. For news overview, click below.
Learn about UNION’s pipeline, including our efforts within immune-dermatology, such as Atopic Dermatitis, Psoriasis and Hidradenitis Suppurativa, as well as our work in COVID-19 and respiratory infections.
Indhold her.
UNION constantly seeks like-minded and talented drug developers, scientists, clinical specialists, and business developers at any level who share our passion for improving the health of humans affected by immunological disorders and infectious diseases.
